Legal Representation
Attorney
Michael T. Olsen
USPTO Deadlines
Next Deadline
1322 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-02-19)
Due Date
February 19, 2029
Grace Period Ends
August 19, 2029
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 24, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Feb 19, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Sep 15, 2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Sep 15, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sep 15, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sep 15, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sep 15, 2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Sep 15, 2021 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Jul 28, 2021 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| May 29, 2019 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Feb 19, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jan 17, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jan 16, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Jan 16, 2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jan 16, 2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Jan 16, 2019 | SNEA | W | SU-EXAMINER'S AMENDMENT WRITTEN |
| Jan 16, 2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Dec 11, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Dec 11, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 11, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jun 11, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 11, 2018 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Jun 11, 2018 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| May 23, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| May 23, 2018 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
| May 23, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| May 14, 2018 | IUAF | S | USE AMENDMENT FILED |
| May 14, 2018 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
| May 14, 2018 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
| May 14, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Nov 29, 2017 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Nov 29, 2017 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Nov 14, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 19, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 19, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 30, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 14, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 14, 2017 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Aug 14, 2017 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Aug 14, 2017 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Aug 14, 2017 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jul 13, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jul 13, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 7, 2017 | ALIE | A | ASSIGNED TO LIE |
| Jul 5, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Feb 17, 2017 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Feb 17, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 17, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Feb 8, 2017 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 25, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Detailed Classifications
Class 041
Educational services, namely, providing and conducting classes, seminars, symposiums, conferences and workshops in the field of pharmaceutical product development of medicines, healthcare, cancer treatment and cannabinoid medicines; instruction services in the field of pharmaceutical product development of medicines, cancer treatments and cannabinoid medicines
First Use Anywhere:
20180200
First Use in Commerce:
20180200
Class 042
Scientific and technological services, namely, scientific research, analysis, testing in the field of medicines, healthcare, and cancer treatment, and research and new product design services relating thereto, all not involving cannabinoid medicines; chemical analysis not involving cannabinoid medicines; chemical research not involving cannabinoid medicines; research and development in the field of medicines, healthcare, and cancer treatment, not involving cannabinoid medicines; and Scientific and technological services, namely, scientific research, analysis, testing in the field of cannabinoid medicine development, and research and new product design services relating thereto, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical research involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; research and development in the field of cannabinoid medicines involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols
First Use Anywhere:
20180200
First Use in Commerce:
20180200
Classification
International Classes
041
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCES"